114 related articles for article (PubMed ID: 22677787)
1. The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP.
Cabiati M; Caruso R; Caselli C; Frigerio M; Prescimone T; Parodi O; Giannessi D; Del Ry S
Peptides; 2012 Aug; 36(2):192-8. PubMed ID: 22677787
[TBL] [Abstract][Full Text] [Related]
2. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
3. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
4. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
Palmer SC; Prickett TC; Espiner EA; Yandle TG; Richards AM
Hypertension; 2009 Sep; 54(3):612-8. PubMed ID: 19620509
[TBL] [Abstract][Full Text] [Related]
5. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly.
Cappellin E; Gatti R; Antonelli G; Soldà G; Ragazzi E; De Palo EF; Spinella P
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):308-13. PubMed ID: 22498997
[TBL] [Abstract][Full Text] [Related]
7. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
9. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P
Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
12. Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients.
Del Ry S; Cabiati M; Stefano T; Catapano G; Caselli C; Prescimone T; Passino C; Emdin M; Giannessi D
Regul Pept; 2011 Jan; 166(1-3):15-20. PubMed ID: 20800621
[TBL] [Abstract][Full Text] [Related]
13. Alterations of natriuretic peptides amino-terminal pro B-type natriuretic peptide and amino-terminal pro C-type natriuretic peptide during the pregnancy.
Tekin YB; Güven ES; Kırbaş A; Cobanoğlu U; Colak S; Doğan OD; Sahin FK
J Matern Fetal Neonatal Med; 2014 Jul; 27(11):1103-7. PubMed ID: 24090090
[TBL] [Abstract][Full Text] [Related]
14. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
15. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury.
Scolletta S; Carlucci F; Biagioli B; Marchetti L; Maccherini M; Carlucci G; Rosi F; Salvi M; Tabucchi A
Biomed Pharmacother; 2007; 61(2-3):160-6. PubMed ID: 17350221
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of changes in N-terminal pro-brain natriuretic Peptide combined with sequential organ failure assessment scores in patients with acute lung injury/acute respiratory distress syndrome concomitant with septic shock.
Park BH; Park MS; Kim YS; Kim SK; Kang YA; Jung JY; Lim JE; Kim EY; Chang J
Shock; 2011 Aug; 36(2):109-14. PubMed ID: 21478812
[TBL] [Abstract][Full Text] [Related]
19. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients.
Ilea M; Zdrenghea D; Bodisz G; Mălai A; Gheorghiu L; Predescu D; Beudean M; Ossian V; Gligor E; Vlad C; Pop D; Bogdan E; Roşu R
Rom J Intern Med; 2008; 46(1):63-8. PubMed ID: 19157272
[TBL] [Abstract][Full Text] [Related]
20. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
